The emergence of Mycobacterium tuberculosis with complex drug resistance profiles necessitates a rapid and comprehensive drug susceptibility test for guidance of patient treatment. We developed two targeted-sequencing workflows based on Illumina MiSeq and Nanopore MinION for the prediction of drug resistance in M.
tuberculosis toward 12 antibiotics.A total of 163 M. tuberculosis isolates collected from Hong Kong and Ethiopia were subjected to a multiplex PCR for simultaneous amplification of 19 drug resistance-associated genetic regions.
The amplicons were then barcoded and sequenced in parallel on MiSeq and MinION in respective batch sizes of 24 and 12 samples. A web-based bioinformatics pipeline, BacterioChek-TB, was developed to translate the raw datasets into clinician-friendly reports.Both platforms successfully sequenced all samples with mean read depths of 1,127× and 1,649×, respectively.
The variant calling by MiSeq and MinION could achieve 100% agreement if variants with an allele frequency of <40% reported by MinION were excluded. Both workflows achieved a mean clinical sensitivity of 94.8% and clinical specificity of 98.0% when compared with phenotypic drug susceptibility test (pDST).
Turnaround times for the MiSeq and MinION workflows were 38 and 15 h, facilitating the delivery of treatment guidance at least 17-18 days earlier than pDST, respectively.
Recombinant Conus emaciatus Conotoxin Ec15a |
|||
| MBS1018544-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 725 |
α-E-Catenin Antibody |
|||
| E90730 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
α-E-Catenin (phospho-Ser652) rabbit pAb |
|||
| E013439 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
α-E-Catenin (phospho-Ser652) rabbit pAb |
|||
| E28PP1556 | EnoGene | 100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
α-E-Catenin (phospho-Ser652) rabbit pAb |
|||
| E44H14637 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
α-E-Catenin (phospho-Ser652) rabbit pAb |
|||
| UB-GEN-16326 | UpingBio | 100 ul | EUR 200 |
Recombinant Echis carinatus Disintegrin EC3A |
|||
| MBS1024789-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Echis carinatus Disintegrin EC3A |
|||
| MBS1024789-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Echis carinatus Disintegrin EC3A |
|||
| MBS1024789-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Echis carinatus Disintegrin EC3A |
|||
| MBS1024789-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Echis carinatus Disintegrin EC3A |
|||
| MBS1024789-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
EC55989_2174 Antibody |
|||
| CSB-PA487466XA01ENM-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_2174 protein |
|||
EC55989_2174 Antibody |
|||
| CSB-PA487466XA01ENM-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_2174 protein |
|||
EC55989_2495 Antibody |
|||
| CSB-PA484952XA01ENM-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_2495 protein |
|||
EC55989_2495 Antibody |
|||
| CSB-PA484952XA01ENM-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_2495 protein |
|||
EC55989_1114 Antibody |
|||
| CSB-PA484131XA01ENM-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_1114 protein |
|||
EC55989_1114 Antibody |
|||
| CSB-PA484131XA01ENM-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Escherichia coli (strain 55989 / EAEC) EC55989_1114 protein |
|||
Recombinant Echis carinatus sochureki Disintegrin EC6A |
|||
| MBS1099744-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Echis carinatus sochureki Disintegrin EC6A |
|||
| MBS1099744-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Echis carinatus sochureki Disintegrin EC6A |
|||
| MBS1099744-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Echis carinatus sochureki Disintegrin EC6A |
|||
| MBS1099744-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Echis carinatus sochureki Disintegrin EC6A |
|||
| MBS1099744-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Saccharomyces cerevisiae UPF0507 protein EC1118_1M3_1541g (EC1118_1M3_1541g, EC1118_1M3_1552g), partial |
|||
| MBS1113536-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EC-5026 |
|||
| 555766 | MedKoo Biosciences | 5.0mg | EUR 90 |
EC-5062 |
|||
| MBS133100-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EC0489 |
|||
| HY-114306 | MedChemExpress | Get quote | Ask for price |
|
Description: EC0489, a conjugate of folic acid and desacetyl vinblastine hydrazide, is a high-affinity ligand for the folate receptor (FR). Refractory or metastatic Tumor[1]. Small molecule-agent conjugate (SMDC)[2]. |
|||
EC5026 |
|||
| HY-135653 | MedChemExpress | 10 mg | EUR 535.72 |
|
Description: EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain[1]. |
|||
EC1454 |
|||
| HY-128937 | MedChemExpress | Get quote | Ask for price |
|
Description: EC1454 is an anti-tumor compound, extracted from US20170348376A1[1]. |
|||
EC1167 |
|||
| HY-128938 | MedChemExpress | Get quote | Ask for price |
|
Description: EC1167 is the linker for EC1169. EC1169 is prostate-specific membrane antigen targeting-tubulysin conjugate. EC1169 has the potential to treat recurrent metastatic, castration-resistant prostate cancer (MCRPC)[1]. |
|||
EC0488 |
|||
| HY-128939 | MedChemExpress | Get quote | Ask for price |
|
Description: EC0488 is used to synthesize EC0531 with folate receptor (FR)-specific and anti-tumor activities[1]. |
|||
EC0488 |
|||
| MBS3842883-10mg | MyBiosource | 10mg | EUR 1905 |
EC0488 |
|||
| MBS3842883-1mg | MyBiosource | 1mg | EUR 430 |
EC0488 |
|||
| MBS3842883-5mg | MyBiosource | 5mg | EUR 1165 |
EC0488 |
|||
| MBS3842883-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
EC1167 |
|||
| MBS3842887-10mg | MyBiosource | 10mg | EUR 290 |
EC1167 |
|||
| MBS3842887-5mg | MyBiosource | 5mg | EUR 210 |
EC1167 |
|||
| MBS3842887-5x10mg | MyBiosource | 5x10mg | EUR 1305 |
EC1454 |
|||
| MBS3842891-10mg | MyBiosource | 10mg | EUR 1905 |
EC1454 |
|||
| MBS3842891-1mg | MyBiosource | 1mg | EUR 430 |
EC1454 |
|||
| MBS3842891-5mg | MyBiosource | 5mg | EUR 1165 |
EC1454 |
|||
| MBS3842891-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
EC0489 |
|||
| MBS3843191-10mg | MyBiosource | 10mg | EUR 810 |
EC0489 |
|||
| MBS3843191-50mg | MyBiosource | 50mg | EUR 2370 |
EC0489 |
|||
| MBS3843191-5mg | MyBiosource | 5mg | EUR 465 |
EC0489 |
|||
| MBS3843191-5x50mg | MyBiosource | 5x50mg | EUR 10655 |
EC5026 |
|||
| MBS5753067-10mg | MyBiosource | 10mg | EUR 195 |
EC5026 |
|||
| MBS5753067-25mg | MyBiosource | 25mg | EUR 260 |
EC5026 |
|||
| MBS5753067-2mg | MyBiosource | 2mg | EUR 145 |
EC5026 |
|||
| MBS5753067-50mg | MyBiosource | 50mg | EUR 395 |
EC5026 |
|||
| MBS5753067-5mg | MyBiosource | 5mg | EUR 160 |
EC0488 |
|||
| MBS5766562-5mg | MyBiosource | 5mg | EUR 915 |
EC0488 |
|||
| MBS5766562-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
EC1454 |
|||
| MBS5766563-5mg | MyBiosource | 5mg | EUR 915 |
EC1454 |
|||
| MBS5766563-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
EC0489 |
|||
| MBS5768045-5mg | MyBiosource | 5mg | EUR 915 |
EC0489 |
|||
| MBS5768045-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
EC2629 |
|||
| MBS5800171-5mg | MyBiosource | 5(mg | EUR 915 |
EC2629 |
|||
| MBS5800171-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
EC1167 |
|||
| T17930-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC1167 |
|||
EC1167 |
|||
| T17930-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC1167 |
|||
EC1167 |
|||
| T17930-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC1167 |
|||
EC1167 |
|||
| T17930-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC1167 |
|||
EC1167 |
|||
| T17930-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC1167 |
|||
EC0488 |
|||
| T11144-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC0488 |
|||
EC0488 |
|||
| T11144-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC0488 |
|||
EC0488 |
|||
| T11144-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC0488 |
|||
EC0488 |
|||
| T11144-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC0488 |
|||
EC0488 |
|||
| T11144-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC0488 |
|||
EC1454 |
|||
| T11145-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC1454 |
|||
EC1454 |
|||
| T11145-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC1454 |
|||
EC1454 |
|||
| T11145-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC1454 |
|||
EC1454 |
|||
| T11145-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC1454 |
|||
EC1454 |
|||
| T11145-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC1454 |
|||
EC5026 |
|||
| T11147-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC5026 |
|||
EC5026 |
|||
| T11147-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC5026 |
|||
EC5026 |
|||
| T11147-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC5026 |
|||
EC5026 |
|||
| T11147-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC5026 |
|||
EC5026 |
|||
| T11147-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC5026 |
|||
EC0489 |
|||
| T13672-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC0489 |
|||
EC0489 |
|||
| T13672-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC0489 |
|||
EC0489 |
|||
| T13672-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC0489 |
|||
EC0489 |
|||
| T13672-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC0489 |
|||
EC0489 |
|||
| T13672-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC0489 |
|||
EC2629 |
|||
| T39757-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC2629 |
|||
EC2629 |
|||
| T39757-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC2629 |
|||
EC2629 |
|||
| T39757-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC2629 |
|||
EC2629 |
|||
| T39757-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC2629 |
|||
EC2629 |
|||
| T39757-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC2629 |
|||
(Rac)-EC5026 |
|||
| HY-135653A | MedChemExpress | 10 mg | EUR 1569.29 |
|
Description: (Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson's disease and dementia with Lewy Bodies (DLB)[1]. |
|||
(Rac)-EC5026 |
|||
| T9832-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (Rac)-EC5026 |
|||
(Rac)-EC5026 |
|||
| T9832-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (Rac)-EC5026 |
|||
(Rac)-EC5026 |
|||
| T9832-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (Rac)-EC5026 |
|||
(Rac)-EC5026 |
|||
| T9832-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (Rac)-EC5026 |
|||
(Rac)-EC5026 |
|||
| T9832-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (Rac)-EC5026 |
|||
Recombinant Escherichia coli CinA-like protein (EC55989_2495) |
|||
| MBS1190398-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1270 |
Recombinant Escherichia coli CinA-like protein (EC55989_2495) |
|||
| MBS1190398-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 945 |
Recombinant Escherichia coli CinA-like protein (EC55989_2495) |
|||
| MBS1190398-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1065 |
Recombinant Escherichia coli CinA-like protein (EC55989_2495) |
|||
| MBS1190398-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1135 |
Recombinant Escherichia coli CinA-like protein (EC55989_2495) |
|||
| MBS1190398-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1210 |
EC1118_1N9_3125g Antibody |
|||
| CSB-PA510583XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1N9_3125g protein |
|||
EC1118_1N9_3125g Antibody |
|||
| CSB-PA510583XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1N9_3125g protein |
|||
EC1118_1M3_1541g Antibody |
|||
| CSB-PA513183XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_1541g protein |
|||
EC1118_1M3_1541g Antibody |
|||
| CSB-PA513183XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_1541g protein |
|||
EC1118_1M3_2531g Antibody |
|||
| CSB-PA513184XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_2531g protein |
|||
EC1118_1M3_2531g Antibody |
|||
| CSB-PA513184XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_2531g protein |
|||
EC1118_1M3_2520g Antibody |
|||
| CSB-PA513912XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_2520g protein |
|||
EC1118_1M3_2520g Antibody |
|||
| CSB-PA513912XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1M3_2520g protein |
|||
EC1118_1L10_0100g Antibody |
|||
| CSB-PA513181XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1L10_0100g protein |
|||
EC1118_1L10_0100g Antibody |
|||
| CSB-PA513181XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1L10_0100g protein |
|||
EC1118_1B15_2135g Antibody |
|||
| CSB-PA514204XA01SVN-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1B15_2135g protein |
|||
EC1118_1B15_2135g Antibody |
|||
| CSB-PA514204XA01SVN-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Saccharomyces cerevisiae (strain Lalvin EC1118 / Prise de mousse) (Baker's yeast) EC1118_1B15_2135g protein |
|||
Rabbit anti-Escherichia coli (strain 55989/EAEC) EC55989_1114 Polyclonal Antibody |
|||
| MBS7174499-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Escherichia coli (strain 55989/EAEC) EC55989_2495 Polyclonal Antibody |
|||
| MBS7175251-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Escherichia coli (strain 55989/EAEC) EC55989_2174 Polyclonal Antibody |
|||
| MBS7177554-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein EC1118_1N9_3125g (EC1118_1N9_3125g) |
|||
| MBS1154053-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Saccharomyces cerevisiae Uncharacterized protein EC1118_1M3_2531g (EC1118_1M3_2531g) |
|||
| MBS1199352-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1300 |
Recombinant Saccharomyces cerevisiae Uncharacterized protein EC1118_1M3_2531g (EC1118_1M3_2531g) |
|||
| MBS1199352-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 985 |
Recombinant Saccharomyces cerevisiae Uncharacterized protein EC1118_1M3_2531g (EC1118_1M3_2531g) |
|||
| MBS1199352-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1095 |
Recombinant Saccharomyces cerevisiae Uncharacterized protein EC1118_1M3_2531g (EC1118_1M3_2531g) |
|||
| MBS1199352-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1150 |
Recombinant Saccharomyces cerevisiae Uncharacterized protein EC1118_1M3_2531g (EC1118_1M3_2531g) |
|||
| MBS1199352-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1245 |
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein EC1118_1N9_3125g (EC1118_1N9_3125g) |
|||
| MBS7040023-002mg | MyBiosource | 0.02mg | EUR 1625 |
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein EC1118_1N9_3125g (EC1118_1N9_3125g) |
|||
| MBS7040023-01mg | MyBiosource | 0.1mg | EUR 2580 |
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein EC1118_1N9_3125g (EC1118_1N9_3125g) |
|||
| MBS7040023-5x01mg | MyBiosource | 5x0.1mg | EUR 11575 |
EC330 |
|||
| 462567 | MedKoo Biosciences | 1.0mg | EUR 260 |
EC-109 |
|||
| ABC-TC508S | AcceGen | 1 vial | Ask for price |
|
Description: Tissue: Esophagus; Esophageal cancer cell lines. |
|||
EC330 |
|||
| MBS132904-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EC144 |
|||
| HY-13479 | MedChemExpress | 10 mg | EUR 963.22 |
|
Description: EC144 is a potent and selective inhibitor of heat shock protein 90 (Hsp90) with an IC50 of 1.1 nM. EC144 inhibits tumor growth and causes partial tumor regressions. EC144 has the potential for the research of cancer diseases[1]. EC144 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
|||
EC330 |
|||
| HY-100949 | MedChemExpress | 50mg | EUR 1428.59 |
|
Description: EC330 is a leukemia inhibitory factor (LIF) inhibitor. EC330 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
|||
EC089 |
|||
| HY-128940 | MedChemExpress | Get quote | Ask for price |
|
Description: EC089 is a cleavable linker used in conjugates of tubulysins and folates, and extracted from patent WO2011069116A1[1]. |
|||
EC359 |
|||
| HY-120142 | MedChemExpress | 10 mg | EUR 1785.74 |
|
Description: EC359 is a potent, selective, high affinity and orally active leukemia inhibitory factor receptor (LIFR) inhibitor with a Kd of 10.2 nM, which directly interacts with LIFR to effectively block LIF/LIFR interactions[1]. EC359 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
|||
EC330 |
|||
| MBS3610713-10mg | MyBiosource | 10mg | EUR 555 |
EC330 |
|||
| MBS3610713-25mg | MyBiosource | 25mg | EUR 880 |
EC330 |
|||
| MBS3610713-5mg | MyBiosource | 5mg | EUR 415 |
EC330 |
|||
| MBS3610713-5x25mg | MyBiosource | 5x25mg | EUR 3630 |
EC330 |
|||
| MBS3840056-10mg | MyBiosource | 10mg | EUR 800 |
EC330 |
|||
| MBS3840056-1mg | MyBiosource | 1mg | EUR 220 |
EC330 |
|||
| MBS3840056-50mg | MyBiosource | 50mg | EUR 2290 |
EC330 |
|||
| MBS3840056-5mg | MyBiosource | 5mg | EUR 495 |
EC330 |
|||
| MBS3840056-5x50mg | MyBiosource | 5x50mg | EUR 10300 |
EC089 |
|||
| MBS3842879-10mg | MyBiosource | 10mg | EUR 1905 |
EC089 |
|||
| MBS3842879-1mg | MyBiosource | 1mg | EUR 430 |
EC089 |
|||
| MBS3842879-5mg | MyBiosource | 5mg | EUR 1165 |
EC089 |
|||
| MBS3842879-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
EC359 |
|||
| MBS5753066-100mg | MyBiosource | 100mg | EUR 2840 |
EC359 |
|||
| MBS5753066-50mg | MyBiosource | 50mg | EUR 1905 |
EC359 |
|||
| MBS5753066-5x100mg | MyBiosource | 5x100mg | EUR 12620 |
EC330 |
|||
| MBS5752441-10mg | MyBiosource | 10mg | EUR 380 |
EC330 |
|||
| MBS5752441-1mg | MyBiosource | 1mg | EUR 170 |
EC330 |
|||
| MBS5752441-25mg | MyBiosource | 25mg | EUR 640 |
EC330 |
|||
| MBS5752441-50mg | MyBiosource | 50mg | EUR 920 |
EC330 |
|||
| MBS5752441-5mg | MyBiosource | 5mg | EUR 290 |
EC089 |
|||
| T17929-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC089 |
|||
EC089 |
|||
| T17929-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC089 |
|||
EC089 |
|||
| T17929-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC089 |
|||
EC089 |
|||
| T17929-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC089 |
|||
EC089 |
|||
| T17929-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC089 |
|||
EC359 |
|||
| T11146-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC359 |
|||
EC359 |
|||
| T11146-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC359 |
|||
EC359 |
|||
| T11146-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC359 |
|||
EC359 |
|||
| T11146-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC359 |
|||
EC359 |
|||
| T11146-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC359 |
|||
EC330 |
|||
| T7293-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EC330 |
|||
EC330 |
|||
| T7293-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EC330 |
|||
EC330 |
|||
| T7293-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EC330 |
|||
EC330 |
|||
| T7293-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EC330 |
|||
EC330 |
|||
| T7293-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EC330 |
|||
EC1167 (hydrochloride) |
|||
| HY-128938A | MedChemExpress | 10 mg | EUR 1569.29 |
|
Description: EC1167 hydrochloride is the linker for EC1169. EC1169 is prostate-specific membrane antigen targeting-tubulysin conjugate. EC1169 hydrochloride has the potential to treat recurrent metastatic, castration-resistant prostate cancer (MCRPC)[1]. |
|||
Recombinant Saccharomyces cerevisiae Vacuolar membrane protein EC1118_1N9_3125g (EC1118_1N9_3125g), partial |
|||
| MBS7069187-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein EC1118_1L10_0100g (EC1118_1L10_0100g) |
|||
| MBS1071433-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein EC1118_1L10_0100g (EC1118_1L10_0100g) |
|||
| MBS7039728-002mg | MyBiosource | 0.02mg | EUR 1425 |
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein EC1118_1L10_0100g (EC1118_1L10_0100g) |
|||
| MBS7039728-01mg | MyBiosource | 0.1mg | EUR 2390 |
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein EC1118_1L10_0100g (EC1118_1L10_0100g) |
|||
| MBS7039728-5x01mg | MyBiosource | 5x0.1mg | EUR 10715 |
EC-109 cells |
|||
| C0013001 | Addexbio | One Frozen vial | EUR 620 |
EC-109 Cells |
|||
| 116149 | Antibody Research Corporation | 1 Vial | Ask for price |
EC-109 Cells |
|||
| 116149L | Antibody Research Corporation | 0.5 mg | Ask for price |
EC-109 Cells |
|||
| 116149R | Antibody Research Corporation | 100 µg | Ask for price |
External printer for EC-35 and EC-45 |
|||
| 1001502 | Phoenix instrument | each | EUR 278 |
Recombinant Saccharomyces cerevisiae Probable zinc metalloprotease EC1118_1B15_2135g (EC1118_1B15_2135g), partial |
|||
| MBS1005436-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 3435 |
Recombinant Saccharomyces cerevisiae Probable zinc metalloprotease EC1118_1B15_2135g (EC1118_1B15_2135g), partial |
|||
| MBS1005436-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 3925 |
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein EC1118_1L10_0100g (EC1118_1L10_0100g), partial |
|||
| MBS7069358-INQUIRE | MyBiosource | INQUIRE | Ask for price |
The higher cost per sample on the MinION platform ($71.56) versus the MiSeq platform ($67.83) was attributed to differences in batching capabilities.Our study demonstrates the interchangeability of MiSeq and MinION platforms for generation of accurate and actionable results for the treatment of tuberculosis.